SC
IRON icon

SummitTX Capital’s Disc Medicine IRON Stock Holding History

SummitTX Capital’s Portfolio IRON Stock Details IRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$461K Sell
6,309
-7,511
-54% -$516K 0.01% 607
2026
Q1 		$884K Buy
+13,820
New +$959K 0.03% 467

Other funds holding IRON

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

SummitTX Capital's IRON Position: Q2 2026 in Review

SummitTX Capital reduced its Disc Medicine (IRON) stake by 54% in Q2 2026, selling an estimated $516K and leaving 6,309 shares worth $461K. The position accounts for 0.01% of the portfolio, ranked #607.

SummitTX Capital first reported a position in IRON in Q1 2026 and has held it in 2 quarters since. The position peaked at $884K in Q1 2026. 216 funds tracked by Wall St. Rank hold IRON as of Q2 2026.

  • SummitTX Capital held 6,309 shares of Disc Medicine worth $461K as of Q2 2026.
  • SummitTX Capital sold 7,511 Disc Medicine shares in Q2 2026, an estimated $516K.
  • Disc Medicine made up 0.01% of SummitTX Capital's portfolio in Q2 2026, its #607 holding.
  • SummitTX Capital first reported a position in Disc Medicine in Q1 2026 and has held it in 2 quarters since.
  • SummitTX Capital's Disc Medicine position peaked at $884K in Q1 2026.
  • 216 funds tracked by Wall St. Rank held Disc Medicine as of Q2 2026.

Based on SummitTX Capital's 13F filing for Q2 2026, filed 14 Aug 2026.